Northern Trust
DSGN icon

Northern Trust’s Design Therapeutics DSGN Stock Holding History

Northern Trust’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.11M Buy
353,197
+52,918
+18% +$660K ﹤0.01% 2611
2026
Q1 		$3.19M Buy
300,279
+13,707
+5% +$139K ﹤0.01% 2700
2025
Q4 		$2.69M Sell
286,572
-9,957
-3% -$78K ﹤0.01% 2824
2025
Q3 		$2.23M Sell
296,529
-65,989
-18% -$331K ﹤0.01% 2974
2025
Q2 		$1.22M Sell
362,518
-11,135
-3% -$41.7K ﹤0.01% 3281
2025
Q1 		$1.44M Sell
373,653
-14,472
-4% -$69K ﹤0.01% 3102
2024
Q4 		$2.39M Buy
388,125
+51,351
+15% +$297K ﹤0.01% 2919
2024
Q3 		$1.81M Sell
336,774
-571
-0.2% -$2.69K ﹤0.01% 3062
2024
Q2 		$1.13M Sell
337,345
-19,939
-6% -$77.7K ﹤0.01% 3193
2024
Q1 		$1.44M Sell
357,284
-15,643
-4% -$41.8K ﹤0.01% 3143
2023
Q4 		$988K Buy
372,927
+49,668
+15% +$114K ﹤0.01% 3322
2023
Q3 		$763K Sell
323,259
-1,479
-0.5% -$6.9K ﹤0.01% 3380
2023
Q2 		$2.05M Buy
324,738
+48,970
+18% +$300K ﹤0.01% 2993
2023
Q1 		$1.59M Sell
275,768
-3,362
-1% -$25.1K ﹤0.01% 3035
2022
Q4 		$2.86M Sell
279,130
-4,565
-2% -$61.9K ﹤0.01% 2801
2022
Q3 		$4.74M Buy
283,695
+25,673
+10% +$511K ﹤0.01% 2521
2022
Q2 		$3.61M Buy
258,022
+46,988
+22% +$635K ﹤0.01% 2713
2022
Q1 		$3.41M Sell
211,034
-981
-0.5% -$15K ﹤0.01% 2806
2021
Q4 		$4.54M Buy
212,015
+89,183
+73% +$1.53M ﹤0.01% 2742
2021
Q3 		$1.8M Sell
122,832
-12,695
-9% -$211K ﹤0.01% 3345
2021
Q2 		$2.7M Buy
+135,527
New +$3.42M ﹤0.01% 3214

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's DSGN Position: Q2 2026 in Review

Northern Trust increased its Design Therapeutics (DSGN) stake by 18% in Q2 2026, buying an estimated $660K and bringing the position to 353,197 shares worth $5.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2611.

Northern Trust first reported a position in DSGN in Q2 2021 and has held it in 21 quarters since. 137 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Northern Trust held 353,197 shares of Design Therapeutics worth $5.11M as of Q2 2026.
  • Northern Trust bought 52,918 Design Therapeutics shares in Q2 2026, an estimated $660K.
  • Design Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2611 holding.
  • Northern Trust first reported a position in Design Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 137 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.